PubMed Health⌕ Search

Biomedical subjects

H R Manasse

Publications and source records attributed to H R Manasse.

14 recordsLinked to original sources
PubMed1992

Pharmaceutical services in rural hospitals in Illinois--1991.

The results of a 1991 survey of pharmaceutical services in rural hospitals in Illinois are reported and compared with the results of previously published national and regional surveys. A questionnaire was developed and mailed to the director of pharmacy at each hospital in the study population (n = 95 rural hospitals in Illinois) to obtain information about inpatient drug distribution services, ambulatory-care services, clinical services, and human resources. The response rate was 81% (77 usable responses). Respondents reported a mean hospital size of 115.5 licensed beds. The mean average daily census was 51.2. Drug distribution systems appear similar to those reported in the 1990 ASHP survey, with complete unit dose drug distribution systems existing in 90.1% of respondent rural Illinois hospitals and complete and comprehensive i.v. admixture services in 71.2%. The percentage of pharmacy departments that are decentralized is lower among rural Illinois hospitals than among previous survey populations. Respondents indicated that they provided the following clinical pharmacy services: drug therapy monitoring (73%), patient rounds (12.2%), nutritional support (37.8%), pharmacokinetic consultations (32.4%), and patient education and counseling (24.3%). These results are comparable to those reported in previous surveys. Respondents reported an average of 5.9 full-time equivalents per hospital pharmacy department. The pharmacist vacancy rate and the total vacancy rate per department were reported as 10% and 5.3%, respectively, with vacant positions taking an average of 15 months to fill. The pharmacist vacancy rate is markedly higher than that reported in the 1990 ASHP survey. Rural Illinois hospitals are comparable to other U.S. hospitals in the provision of most pharmaceutical services.(ABSTRACT TRUNCATED AT 250 WORDS)

Ambulatory Care↗
PubMed1989

Medication use in an imperfect world: drug misadventuring as an issue of public policy, Part 1.

Drug misadventuring is defined, applicable public policy issues are identified and analyzed, and recommendations are suggested for reducing the magnitude and scope of drug misadventuring. The extensive use of pharmaceuticals in the United States, as well as the error-prone systems that are responsible for the appropriate preparation and distribution of drugs, has created new challenges for prescribers, dispensers, and users of drugs. The term "drug misadventuring" covers the broad array of phenomena associated with negative drug experiences. Studies conducted in the United States during the past two decades related to drug misadventuring have been inadequate. Further, extrapolation of data from these studies to the population at large has yielded false projections of the extent of the problem. Since drug misadventuring is a human problem, it is derived from the actions or inactions of a variety of "environments"--social, economic, political, and scientific-technological--that define American society. The following players directly influence decisions associated with drug misadventuring: prescribers, patients, pharmacists, manufacturers, policymakers, and third-party payers. Conflicts of interest among these groups and environmental sectors deter progress in minimizing drug misadventuring. The problem of drug misadventuring must be viewed as a problem in public policy, and new policy decisions must be constructed in the best interest of the patient. Recommendations are made for a "new order" in confronting and resolving this problem. Bold leadership and forthright discussion will be required to find solutions to the problem of drug misadventuring.

Drug Industry↗